# Vitalant – FDA Inspection, May 8, 2017

Source: https://www.keypedia.com/records/fda_inspections/vitalant/a36ac619-b859-4c68-b712-fc3d6afeb9a5
Source feed: FDA_Inspections

> FDA inspection 1011386 of Vitalant, May 08, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 606. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1011386
- Company Name: Vitalant
- Inspection Date: 2017-05-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1277492 - 2025-07-18
- FDA Inspection 1154344 - 2021-09-24
- FDA Inspection 1106094 - 2019-09-20
- [FDA Inspection 924066 - 2015-04-30](https://www.keypedia.com/records/fda_inspections/vitalant/61b9e299-b13c-4e4b-b5a8-2a484f0a7de7)
- FDA Inspection 837856 - 2013-06-26

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kathryn-a-krentz/9523b161-3b81-4a1b-aaca-c0406d756ab4)

Company: https://www.keypedia.com/companies/vitalant/5f6be220-1a80-43de-9256-9b844fee506a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d